Cargando…
Role of metabolic manipulator trimetazidine in limiting percutaneous coronary intervention–induced myocardial injury
BACKGROUND: Trimetazidine (TMZ) is a metabolic modulator that shifts substrate utilization from fatty acid to carbohydrates, thereby, increasing myocardial glucose oxidation and improving myocardial ischemia. We evaluated whether TMZ is effective in reducing myocardial injury after percutaneous coro...
Autores principales: | Kazmi, Danish H., Kapoor, Aditya, Sinha, Archana, Ambesh, Paurush, Kashyap, Shiridhar, Khanna, Roopali, Kumar, Sudeep, Garg, Naveen, Tewari, Satyendra, Goel, Pravin K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309873/ https://www.ncbi.nlm.nih.gov/pubmed/30595291 http://dx.doi.org/10.1016/j.ihj.2018.10.415 |
Ejemplares similares
-
Heart rate manipulation in dilated cardiomyopathy: Assessing the role of Ivabradine
por: Raja, Deep Chandh, et al.
Publicado: (2018) -
Metabolic manipulation in dilated cardiomyopathy: Assessing the role of trimetazidine
por: Jatain, Suman, et al.
Publicado: (2016) -
Metabolic manipulation in Dilated Cardiomyopathy: assessing the role of trimetazidine
por: Kapoor, Aditya, et al.
Publicado: (2015) -
Exploring the Association of Fibrinogen and CRP with the Clinical Spectrum of CAD and Periprocedural Outcomes in Patients Undergoing Percutaneous Coronary Interventions
por: Khandelwal, Vijay, et al.
Publicado: (2022) -
Efficacy of RADPAD protection drape in reducing radiation exposure in the catheterization laboratory—First Indian study
por: Shah, Pujan, et al.
Publicado: (2018)